Summit Therapeutics Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 81
Employees
  • Latest Deal Type
  • PIPE
  • Latest Deal Amount
  • $50M
Latest Deal Amount
  • Investors
  • 1

Summit Therapeutics General Information

Description

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has three geographical segments: United States, Latin America, and Europe.

Contact Information

Formerly Known As
VASTox, Summit Corporation plc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Primary Office
  • 136a Eastern Avenue
  • Milton Park
  • Abingdon OX14 4SB
  • England, United Kingdom
+44 01235 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Summit Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. PIPE 06-Nov-2020 $50M 0000 Completed Generating Revenue/Not Profitable
9. Merger/Acquisition 24-Dec-2019 000.00 00000 00000 Completed Generating Revenue/Not Profitable
8. PIPE 10-Jan-2019 000.00 00000 Completed Generating Revenue/Not Profitable
7. PIPE 27-Mar-2018 000.00 00000 Completed Generating Revenue/Not Profitable
6. 2PO 05-Mar-2015 000.00 00000 00000 Completed Generating Revenue/Not Profitable
5. PIPE 11-Feb-2014 000.00 000.00 Completed Generating Revenue/Not Profitable
4. PIPE 11-Dec-2009 000.00 000.00 Completed Generating Revenue/Not Profitable
3. PIPE 27-Feb-2006 000.00 000.00 Completed Generating Revenue/Not Profitable
2. IPO 14-Oct-2004 $26.9M $26.9M 000.00 Completed Generating Revenue/Not Profitable
1. Early Stage VC 27-Feb-2003 Completed Startup
To view Summit Therapeutics’s complete valuation and funding history, request access »

Summit Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization
Biotechnology
Abingdon, United Kingdom
81 As of 2020
0000
000000000 0000

00000 00

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 00000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

00000000

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000 00000000
Malvern, PA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Summit Therapeutics Competitors (83)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sutro Biopharma Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
00000000 Formerly VC-backed Malvern, PA 00 00000 00000000 00000
0000000 0000000000 Corporation Waconia, MN 0 000.00 00000000 000.00
0000000 000000000 Corporate Backed or Acquired Warminster, PA 00 00000 000000 - 000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 83 competitors. Get the full list »

Summit Therapeutics Executive Team (22)

Name Title Board Seat Contact Info
Michael Donaldson Chief Financial Officer
Mahkam Zanganeh Chief Operating Officer & Director
Dave Powell Chief Scientific Officer
Camilla Graham MD Chief Clinical Affairs Officer
Deepa Venkataraman Head of Global Patient Safety and Pharmacovigilance, Head of Quality Assurance
You’re viewing 5 of 22 executive team members. Get the full list »

Summit Therapeutics Board Members (10)

Name Representing Role Since
Elaine Stracker Summit Therapeutics Board Member 000 0000
Glyn Edwards Summit Therapeutics Chief Executive Officer & Chairman 000 0000
Manmeet Soni Self Board Member 000 0000
Rainer Erdtmann Self Board Member 000 0000
Robert Duggan Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Summit Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Summit Therapeutics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Burnbrae Group Asset Manager Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
Straub Ventures Venture Capital Minority 000 0000 000000 0
To view Summit Therapeutics’s complete investors history, request access »

Summit Therapeutics Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 23-Dec-2017 000000000000000000 000.00 Biotechnology 0000 0000000
0000 22-Nov-2013 000000000000000000 Other Healthcare Technology Systems 0000 0000000
000000000 21-Mar-2007 000000000000000000 000.00 Biotechnology
Dextra Laboratories 21-Mar-2007 Merger/Acquisition 00.000 Laboratory Services (Healthcare) 000000 000
To view Summit Therapeutics’s complete acquisitions history, request access »

Summit Therapeutics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 21-Mar-2007 000000000000000000 00.000 Completed
  • 000000 00000000000
To view Summit Therapeutics’s complete exits history, request access »